October 24th 2024
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
IOM report recommends 8 preventive women's health services
August 9th 2011A new report from the Institute of Medicine recommends that 8 preventive health services for women be added to the services that health plans will cover at no cost to patients under the Patient Protection and Affordable Care Act of 2010.
APhA seeks nominations for profession-wide awards, honors
August 8th 2011The American Pharmacists Association (APhA) is accepting nominations for its annual profession-wide awards and honors. The awards will be presented at the APhA Annual Meeting and Exposition in New Orleans, March 9-12, 2012. The awards represent the pharmacy profession?s most comprehensive recognition program.
Pharmacists play critical role in preparing patients for flu season
August 8th 2011Pharmacies can play a valuable role in helping patients prepare for the upcoming flu season. That includes administering influenza vaccinations, according to results of a public-private partnership campaign in Palm Beach, Fla. The National Association of Chain Drug Stores highlighted the results of the partnership in a report it co-authored that was published in the September/October issue of the Journal of Public Health Management and Practice.
PCMA white paper assailing drugstore lobby "riddled with mistakes," says NCPA
August 8th 2011A new campaign and white paper from the Pharmaceutical Care Management Association that blasts the ?drugstore lobby? is riddled with mistakes and misleading statements, according to the National Community Pharmacists Association.
Fluconazole in early pregnancy may cause birth defects, FDA warns
August 8th 2011FDA issued a warning last week that chronic high doses (400 mg/day to 800 mg/day) of fluconazole (Diflucan) during the first trimester of pregnancy may be associated with specific birth defects in infants. However, according to the Safety Alert released August 3, the risk does not appear to be associated with the single low dose of fluconazole (150 mg) that is used to treat vaginal yeast infection (candidiasis).
Nonpsychiatrist providers may be overprescribing antidepressants
August 2nd 2011More doctors who are not psychiatrists are prescribing antidepressants, making these drugs the third most commonly prescribed group of medications in the United States, according to a study published in the August issue of Health Affairs.
Studies evaluate transition care programs for patients leaving hospital
August 2nd 2011Programs designed to support the care of older patients as they make the transition from the hospital to outside clinicians and healthcare settings are associated with reduced rates of hospital readmissions, according to 2 reports in the July 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
FDA approves subcutaneous formulation of abatacept for treatment of RA
August 1st 2011FDA has approved a subcutaneous (SC) formulation of abatacept (Orencia, Bristol-Myers Squibb) for the treatment of adults with moderate-to-severe rheumatoid arthritis (RA). It is the first biologic available in both SC and intravenous formulations for the treatment of RA.
Tylenol dose lowered to prevent overdose risk
August 1st 2011Johnson and Johnson has announced plans for new dosing instructions that lower the maximum daily dose for single-ingredient Extra Strength Tylenol (acetaminophen) products sold in the United States from 8 pills per day (4,000 mg) to 6 pills per day (3,000 mg).
"Brazilian diet pills" passed off as supplements; smuggler sentenced
August 1st 2011As a result of combined investigations by FDA, the IRS Criminal Division, and the U.S. Department of Justice, Elisane Garcia was sentenced on July 25 for disguising controlled substances as "Brazilian diet pills" and smuggling them into the United States with intent to distribute. She was also convicted of 1 count of money-laundering.
IOM report recommends 8 preventive women's health services
July 26th 2011A new report from the Institute of Medicine (IOM) recommends that 8 preventive health services for women be added to the services that health plans will cover at no cost to patients under the Patient Protection and Affordable Care Act of 2010.
FDA Safety Alert: REMS required with belatacept
July 26th 2011Patients treated with belatacept (Nulojix, Bristol-Myers-Squibb) are at increased risk of developing 2 potentially fatal complications: post-transplant lymphoproliferative disorder (PTLD), which predominantly involves the central nervous system, and progressive multifocal leukoencephalopathy, according to a recent FDA Safety Alert. The risk of PTLD is higher for transplant patients who have never been exposed to Epstein-Barr virus (EBV) and therefore is indicated for use only in transplant patients who are EBV seropositive.
Healthcare groups oppose PPACA's FSA requirement for Rx OTCs
July 25th 2011CVS Caremark, the National Community Pharmacists Association, and several healthcare groups are supporting a new bill that would allow patients to purchase OTC medications through flexible spending accounts (FSAs) and health savings accounts (HSAs).
FDA approves REMS for Fentora, Actiq
July 25th 2011FDA has approved the Risk Evaluation and Mitigation Strategy (REMS) for Fentora (fentanyl buccal tablet) [C-II] and Actiq (oral transmucosal fentanyl citrate) [C-II]. Both products, manufactured by Cephalon, are indicated for management of breakthrough pain in opioid-tolerant patients with cancer.
Longer-term use of pioglitazone associated with an increased risk of bladder cancer
July 25th 2011On June 15, 2011, FDA published an online safety communication informing prescribers and patients that pioglitazone (Actos, Takeda Pharmaceuticals America Inc) use may be associated with a 20% to 40% increased hazard of new bladder cancer.